# FMC Corp: Form 10-Q for the period ended Mar 31, 2011

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2011-05-05
- Accepted by EDGAR: May 5, 2011, 13:44 ET
- Period: 2011-03-31
- Accession: 0000037785-11-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778511000006/fmc331201110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778511000006/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-01-01 to 2011-03-31 | $795.0m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2011-01-01 to 2011-03-31 | $506.9m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2011-01-01 to 2011-03-31 | $105.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2011-01-01 to 2011-03-31 | $155.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2011-01-01 to 2011-03-31 | $40.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-01-01 to 2011-03-31 | $94.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-01-01 to 2011-03-31 | $1.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-01-01 to 2011-03-31 | $1.31 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 3 months, 2011-01-01 to 2011-03-31 | −$50.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2011-01-01 to 2011-03-31 | $30.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2011-01-01 to 2011-03-31 | $9.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2011-01-01 to 2011-03-31 | $3.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2011-03-31 | $86.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-03-31 | $1.72bn | us-gaap:AssetsCurrent |
| Total assets | at 2011-03-31 | $3.42bn | us-gaap:Assets |
| Current liabilities | at 2011-03-31 | $906.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2011-03-31 | $533.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-03-31 | $119.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2011-03-31 | $1.26bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2011-03-31 | 71,740,377 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 63,210 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2010 (the “2010 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part 1 of the 2010 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2010 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2010 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Our Agricultural Products segment develops, markets and sells all three major classes of crop protection chemicals - insecticides, herbicides, and fungicides - with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. Specialty Chemicals consists of our BioPolymer and lithium businesses and focuses on food ingredients that are used to enhance texture, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications, ultrapure biopolymers for medical devices and lithium for energy storage, specialty polymers and pharmaceutical synthesis. Our Industrial Chemicals segment manufactures a wide range of inorganic materials, including soda ash, hydrogen peroxide, specialty peroxygens, zeolites and silicates. Through the end of 2010, our Industrial Chemicals segment held a niche position in phosphorous chemicals products.

### 2011 Year to Date Highlights

Our businesses continue to experience positive results from the increase in global economic activity resulting in higher volumes and in certain cases higher pricing. Results for the three months ended March 31, 2011, reflect increases in both consolidated revenues and earnings driven by solid performance in all three of our operating segments.

Our Agricultural Products segment revenues increased 13 percent from the prior year period, driven by sales gains in North America, Latin America particularly Brazil, and Asia due to improved market conditions in several key crops. Revenue also increased in our Specialty Chemicals segment with revenues up four percent compared to the prior year period. Revenue increases in the Specialty Chemicals segment were led by strong commercial performance in BioPolymer's food ingredient business. These strong segment results were partially offset by reduced revenues of three percent in our Industrial Chemicals segment primarily a result of the exited phosphate business at our Huelva, Spain facility and the exited sulfur derivative business at our Barcelona, Spain facility.

Agricultural Products' operating profit increased eight percent compared to the prior year period, reflecting broad-based sales growth, partially offset by higher spending on targeted growth initiatives. Specialty Chemicals' operating profit grew by 10 percent due to sales gains, favorable mix and operating costs reduction in Lithium, partially offset by higher raw material and energy costs. Industrial Chemicals' operating profit increased 17 percent from the prior year period, primarily driven by higher soda ash and peroxygen sales, augmented by a favorable mix shift in peroxygens toward specialties markets.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2011 Revenue | Three Months Ended March 31, | 2010 |
| --- | ---: | ---: |
| Agricultural Products | $343.6 | $304.6 |
| Specialty Chemicals | 210.1 | 202.6 |
| Industrial Chemicals | 242.5 | 250.1 |
| Eliminations | (1.2) | (0.8) |
| Total | $795.0 | $756.5 |
| **Income (loss) from continuing operations before income taxes** |  |  |
| Agricultural Products | $100.5 | $92.8 |
| Specialty Chemicals | 44.9 | 40.8 |
| Industrial Chemicals | 40.3 | 34.5 |
| Eliminations | (0.1) | 0.2 |
| **Segment operating profit (1)** | 185.6 | 168.3 |
| Corporate | (16.8) | (12.1) |
| Other income (expense), net | (7.3) | (2.9) |
| Interest expense, net | (9.9) | (10.0) |
| Corporate special income (charges): |  |  |
| Restructuring and other (charges) income | (4.5) | (16.7) |
| Non-operating pension and postretirement charges (2) | (4.5) | (2.8) |
| Provision for income taxes | (40.6) | (40.7) |
| Discontinued operations, net of income taxes | (8.0) | (5.7) |
| **Net income attributable to FMC stockholders** | $94.0 | $77.4 |

(1) Results for all segments are net of noncontrolling interests of $3.4 million and $3.0 million for the three months ended March 31, 2011 and 2010, respectively. The majority of these noncontrolling interests pertain to our Industrial Chemicals segment.

(2) Beginning in 2011, we reclassified for all periods presented non-operating pension and postretirement charges to its own line item within the above table. Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs were previously included within Other income (expense), net in the above table and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges and certain tax adjustments from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2011 | Three Months Ended March 31, | 2010 |
| --- | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $94.0 | $77.4 |
| Corporate special charges (income), pre-tax | 9.0 | 19.5 |
| Income tax expense (benefit) on Corporate special charges (income) | (3.1) | (6.1) |
| Corporate special charges (income), net of income taxes | 5.9 | 13.4 |
| Discontinued operations, net of income taxes | 8.0 | 5.7 |
| Tax adjustments | (0.3) | 3.6 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $107.6 | $100.1 |

### Three months ended March 31, 2011 compared to Three months ended March 31, 2010

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out (LIFO) inventory adjustments, amortization of inventory step-up from business acquisitions and other related inventory adjustments, and other income and expense items.

Information about how some of these items relate to our businesses at the segment level is discussed in Note 18 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2010 consolidated financial statements in our 2010 10-K.

### Agricultural Products

*(in Millions)*

| 2011 | Three Months Ended March 31, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $343.6 | $304.6 | $39.0 | 13% |
| Operating Profit | 100.5 | 92.8 | 7.7 | 8 |

Revenue of $343.6 million increased approximately 13 percent versus the prior year quarter due to strong sales in North American, Latin America and Asia, offset by the expected decline in Europe. North America revenue of $117.0 million increased 48 percent due to strong demand for our pre-emergent herbicides, increased sales in the soybean segment, favorable market conditions due to strong commodity prices and a shift in some sales into the first quarter of 2011 from the second quarter due to the favorable market conditions. Latin America revenue of $134.3 million increased 15 percent driven by favorable market conditions, particularly in Brazil's sugarcane and cotton markets, and growth in planted acres for key crops. Revenue in Asia of $61.5 million increased 32 percent reflecting strong market conditions, particularly in Australia, Indonesia and China. As expected, these increases were partially offset by a decline in Europe, Middle East and Africa revenues of 51 percent to $30.8 million. The decline was primarily driven by reduced sales volumes of our bifenthrin product. Sales in Europe were adversely impacted by the ongoing re-registration process for bifenthrin, during which time product may not be sold. Bifenthrin sales in Europe are further discussed below under "Certain Regulatory Issues".

Agricultural Products' operating profit of $100.5 million increased approximately eight percent compared to the year-ago quarter, reflecting the sales volume gains partially offset by the absence of bifenthrin sales in Europe and increased selling and administrative expenses. The increased selling and administrative expenses were primarily due to higher spending on targeted growth initiatives.

In 2011, we expect full-year revenue growth of approximately 10 percent driven by increased volumes, particularly Latin America, Asia and North America, due to expected strong market conditions and growth in new and recently introduced products. Full-year segment operating profit growth of approximately 10 percent reflecting the sales gains partially offset by higher spending on growth initiatives and higher raw material costs.

#### Certain Regulatory Issues

In our Agricultural Products segment, several products are undergoing re-registration in the U.S. and/or a comparable regulatory review by the European Union (“EU”) governmental authorities. In August 2006, the U.S. Environmental Protection Agency (“EPA”) issued its “Interim Reregistration Eligibility Decision” (“IRED”) for our carbofuran insecticide under the U.S. federal pesticide law. The IRED proposed cancellation of all carbofuran uses in the United States, subject to a phase out period for certain minor crop uses, while maintaining tolerances for imported commodities (bananas, coffee, rice and sugarcane). The EPA reiterated its proposal in January 2008, with the issuance of a draft Notice of Intent to cancel carbofuran use (“Notice”). In February 2008, the EPA convened a Scientific Advisory Panel meeting to evaluate scientific issues relevant to the Notice. Separately, the U.S. Department of Agriculture issued its comments on the Notice, stating that carbofuran should continue to be registered. On July 24, 2008, the EPA published a proposal to revoke all carbofuran tolerances under the Federal Food Drug and Cosmetic Act in advance of any issuance of a final Notice under the federal pesticide law. We responded to that notice, expressing our strong disagreement with the EPA's proposal to revoke tolerances and our belief that carbofuran residues on food do not pose a threat to human health. In May 2009, the EPA published its final revocation of all carbofuran tolerances effective December 31, 2009. We filed our objections to this revocation and requested a hearing before an administrative law judge. On October 30, 2009, the EPA denied our objections and our request for a hearing. We believe that we are entitled to a hearing and we have challenged this decision by seeking judicial review in the U.S. federal courts. On July 23, 2010, the U.S. Court of Appeals for the D.C. Circuit ruled that the EPA acted arbitrarily and capriciously in revoking the import tolerances, and ordered that those tolerances be reinstated. However, the Court did not extend its rationale to the domestic tolerances and instead ruled that the EPA had the right to deny our request for administrative hearing. In mid-February 2011, we filed a petition for writ of certiorari, seeking review before the U.S. Supreme Court. In light of the December 31, 2009, tolerance revocation, FMC ceased sales of carbofuran in the United States in 2009. FMC's sales of our carbofuran products in the United States were not significant and termination of such U.S. sales did not have a material effect on the Company's financial condition or results of operations. We do not know the EPA's timing on a final Notice of Intent to Cancel the carbofuran registration, though the EPA has said it intends to issue such notice after the tolerance revocation decision is finally resolved.

In the EU, following an administrative appeals process, the European Commission's proposal to exclude our bifenthrin product from the European Commission's official list of approved pesticides, was adopted on November 30, 2009. FMC had an additional six months to sell bifenthrin in the EU (i.e., through end-May 2010), and subsequently, in most EU countries, there is up to 6-12 months for further sale by distributors or dealers, and use by farmers. On December 30, 2010, the French Ministry of Agriculture issued a notice adding bifenthrin, along with eight other pesticidal active ingredients, to the “Grenelle” list of pesticides. While not superseding the remaining sell-out and usage period allowed by the EU decision, the Grenelle listing has had the practical effect of discouraging product use in France during 2011. At the European level, we have re-submitted for reconsideration and the product dossier is now being reviewed by relevant European authorities. At the French level, we believe that the Grenelle listing was unwarranted and contrary to French administrative law, and we are challenging the decision. Through these efforts, we are seeking to minimize the interruption in existing and future bifenthrin sales in the European market. During 2011, however, we are not selling any bifenthrin for agricultural use into the European Union - absence of such sales will not have a material effect on the Company's financial condition or results of operations.

We intend to defend vigorously all our products in the U.S., EU and other countries' regulatory processes where FMC's pesticide products will be reviewed in the ordinary course of regulatory programs during 2011 as part of the ongoing cycle of re-registration in countries around the world. The Brazilian health surveillance agency has informed us that they intend to review carbofuran along with 13 other major pesticides, but has yet to issue any required formal announcement that identifies their specific concerns or preliminary position on re-registration. FMC is cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect a potential sales impact in Brazil in 2011.

### Specialty Chemicals

*(in Millions)*

| 2011 | Three Months Ended March 31, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $210.1 | $202.6 | $7.5 | 4% |
| Operating Profit | 44.9 | 40.8 | 4.1 | 10 |

Revenue in Specialty Chemicals was $210.1 million, an increase of approximately four percent versus the prior-year quarter. The increase was driven primarily by higher volumes and selling prices in BioPolymer and lithium specialties.

BioPolymer revenue of $159.9 million increased approximately five percent from the prior-year quarter. This increase was due to higher volumes which increased revenue by four percent and favorable pricing offset somewhat by the impact of a weaker euro accounted for the remaining one percent. The volume gains and higher pricing was primarily due to higher sales in BioPolymer's food ingredients business, driven by significantly higher sales of microcrystalline cellulose, or MCC, to beverage and dairy customers in Asia, most notably China.

Lithium revenue of $50.2 million remained flat as compared to prior year. Pricing was up one percent while volumes were down one percent from the prior year. Lithium has been impacted by tightening of supply.

Segment operating profit of $44.9 million increased 10 percent versus the year ago quarter primarily driven by the sales gains, favorable mix and operating cost reductions in Lithium. The higher revenues in BioPolymer did not translate into increased operating profit as these higher revenues were fully offset by higher spending on focused growth initiatives in food ingredients and higher specialty wood pulp and energy costs.

In 2011, we expect full-year revenue growth in the mid-single digits, driven by higher volumes and selling prices in BioPolymer and lithium specialties. Full-year segment operating profit growth of approximately 10 percent is expected, reflecting higher sales and operating cost reductions across the segment, partially offset by higher raw material and energy costs.

As we anticipate ongoing growth for MCC on a global basis, especially high in rapidly developing economies, in March 2011 we completed the expansion of our MCC plant in Cork, Ireland. The expansion, now in full production, increased our global capacity by approximately 25 percent for food and pharmaceutical grade MCC.

### Industrial Chemicals

*(in Millions)*

| 2011 | Three Months Ended March 31, | 2010 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $242.5 | $250.1 | $(7.6) | (3)% |
| Operating Profit | 40.3 | 34.5 | 5.8 | 17 |

Revenue in Industrial Chemicals was $242.5 million, a decrease of approximately three percent versus the prior-year quarter. The decrease is primarily attributable to the exit of our phosphate and sulfur derivative businesses in Spain in 2010. The absence of phosphate and sulfur derivatives revenue in the first quarter of 2011 resulted in overall revenue declines in the segment of 11 percent. The decline in these revenues were partially offset by higher pricing across the segment, particularly in soda ash, which increased revenues by seven percent.

Soda ash revenues were up due to higher pricing particularly in the export market. Export demand continues to be robust, especially in Asia and Latin America. In our domestic market, our volume growth is in line with the demand recovery being experienced in flat glass, detergents and chemicals. The segment also experienced increased pricing and volume growth in our Global Peroxygens division. The increase pricing was across all product lines and volume increases were in the two most significant products, hydrogen peroxide and persulfates.

Segment operating profit of $40.3 million increased approximately 17 percent versus the year ago quarter as a result of the sales gains and the continued favorable mix shift in peroxygens toward specialty markets, partially offset by start-up costs related to our Granger soda ash facility.

In 2011, we expect full-year revenue to be approximately level as growth in soda ash and peroxygens is offset by the absence of revenue from the exited phosphate and sulfur derivative businesses. Full-year operating profit growth of approximately 30 percent driven by higher selling prices and volume growth across the segment augmented by the benefit of cost reduction initiatives.

Recent events in Venezuela, such as hyperinflation, devaluation of currency, government price controls, parallel exchange rates, and political issues have created significant risks and uncertainties for the Venezuelan subsidiaries of multinational corporations. We hold a noncontrolling investment in a Venezuelan phosphate business, Tripoliven C.A., which continues to operate as a profitable business. The value of this investment on our condensed consolidated balance sheet at March 31, 2011 is approximately $9 million. While there has been a lag between the declaration and payment to us of dividends from Tripoliven, we did receive dividends from Tripoliven during 2010. We do not believe there is any impairment of Tripoliven at March 31, 2011. If our investment in Tripoliven were to be totally impaired, it would have an immaterial impact on our liquidity or consolidated financial position, but the impairment charge would have a one-time effect on our results of operations in the period in which it would be recorded.

### Other Results of Operations

#### Corporate expenses

We recorded expenses of $16.8 million in the first quarter of 2011 compared to $12.1 million in first quarter of 2010. The increase was primarily due to increased incentive compensation and consulting expenses incurred during the first quarter of 2011 compared to the same period in 2010. The increase in consulting expenses is a result of the initiatives which began in the latter part of 2010, primarily involving global procurement, aimed at reducing the costs of goods and services purchased on a world-wide basis. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other income (expense), net is comprised primarily of last-in, first-out (“LIFO”) inventory adjustments and certain employee benefits, including incentive compensation. Our business segments account for their inventory utilizing a first-in-first-out ("FIFO") basis of accounting. The LIFO inventory adjustments are not allocated to the business segments and therefore are recorded to "Other income (expense), net". Other expense increased to $7.3 million in the first quarter of 2011 from $2.9 million in the same period of 2010. The increase was primarily due to expense related to an increase in our LIFO inventory reserves in the first quarter 2011. Other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the first quarter of 2011 of $9.9 million was consistent with the first quarter of 2010 of $10.0 million.

#### Corporate special income (charges)

#### Restructuring and other charges (income)

These charges totaled $4.5 million in the first quarter of 2011 compared to $16.7 million in the first quarter of 2010. Please see the table and further discussion regarding our restructuring and other charges (income) in Note 7 to our condensed consolidated financial statements included in this Form 10-Q. Charges (income) in this category for the quarter ended March 31, 2011, include the following:

Restructuring charges and asset impairments:

- A $0.7 million charge primarily related to miscellaneous exit activities associated with our Huelva, Spain facility, which is part of our Industrial Chemicals segment
- A $1.3 million charge related to additional miscellaneous disposal costs associated with our Alginates manufacturing operations in our Specialty Chemicals segment
- A $0.4 million charge from additional miscellaneous exit and disposal costs related to our Santa Clara, Mexico facility, which is part of our Industrial Chemicals segment
- A $0.4 million of severance charges related to other restructuring activities in our Industrial Chemicals and Specialty Chemicals segments

Other charges (income), net:

- Corporate net charges of $1.1 million relating to environmental remediation at operating sites.
- $0.6 million of charges representing the accrual of interest associated with a European Commission fine currently being appealed.

The restructuring and other charges (income) of $16.7 million recorded in the first quarter of 2010 were a result of the following:

Restructuring charges and asset impairments:

- A $4.6 million charge in our Specialty Chemicals segment due to the continued realignment of our BioPolymer alginates manufacturing operations. The charge related to the accrual of costs associated with a leased property which we have ceased using.
- In 2009, we made the decision to close our Bayport butyllithium facility located in Bayport, Texas, which is part of our Specialty Chemicals segment. In the first quarter of 2010, we recorded $0.9 million of income representing a reduction of previously recorded retirement obligations at the site.
- An $8.6 million charge in our Industrial Chemicals segment due to our decision in 2009 to phase out operations of our Barcelona, Spain facility. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of $8.5 million and (ii) other shut down costs of $0.1 million.
- Severance costs due to workforce restructurings of $1.0 million related to our Industrial Chemicals segment.
- $0.1 million of charges primarily representing adjustments related to previously recorded restructuring reserves.

Other charges (income), net:

- Corporate charges of $2.4 million relating to environmental remediation at operating sites.
- $0.9 million of other charges primarily representing the accrual of interest associated with the European Commission fine.

#### Non-operating pension and postretirement charges

The charge for the three months ended March 31, 2011 was $4.5 million compared to $2.8 million for the three months ended March 31, 2010. The increase in charges is a result of amortization related to pension asset losses incurred in 2008. The difference between actual pension investment activity and the estimated rate established at the beginning of each fiscal year results in a gain or loss that is amortized into income over future periods. A decrease in actual plan discount rates in both 2010 and 2009 have also contributed to the higher charges. A decrease in actual plan discount rates compared to the estimated discount rate established at the beginning of the fiscal year results in a loss that is amortized into income over future periods. These expenses are included as a component of the line item "Selling, general and administrative expenses" on our condensed consolidated statements of income.

#### Provision for income taxes

Provision for income taxes was $40.6 million for the first quarter of 2011 compared to a provision of $40.7 million for the prior year period resulting in effective tax rates of 27.8 percent and 32.1 percent, respectively. The change in the effective tax rate was primarily a result of a tax adjustment of $3.5 million recorded during the three months ended March 31, 2010, due to a non-cash charge associated with a change in the tax treatment of the Medicare Part D subsidy which was enacted as part of the 2010 U.S health care reform legislation. This event was not repeated in 2011. The change in the mix of domestic income compared to income earned outside of the U.S. also impacted the effective tax rate. Income we earn domestically is typically taxed at rates higher than income earned outside the U.S.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued between 1976 and 2001. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Discontinued operations, net of income taxes totaled a charge of $8.0 million for the three months ended March 31, 2011, compared to a charge of $5.7 million for the three months ended March 31, 2010. The charge for the three months ended March 31, 2011, primarily related to an increase in our reserves associated with our Middleport site, operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

The charge for the three months ended March 31, 2010, primarily related to environmental charges associated with our Front Royal and Modesto sites as well as operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders increased to $94.0 million for the three months ended March 31, 2011, from $77.4 million for the three months ended March 31, 2010. The increase was primarily due to higher operating profits in all three of our segments and significantly lower restructuring and other charges (income). Partially offsetting this was an increase in corporate expenses and LIFO inventory adjustments.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at March 31, 2011 and December 31, 2010, were $86.0 million and $161.5 million, respectively. At March 31, 2011, we had total debt of $653.6 million as compared to $619.4 million at December 31, 2010. This included $533.9 million and $503.0 million of long-term debt (excluding current portions of $119.7 million and $116.4 million) at March 31, 2011 and December 31, 2010, respectively. Short-term debt, which consists solely of foreign borrowings, decreased to $9.4 million at March 31, 2011, compared to $18.5 million at December 31, 2010.

#### Domestic Credit Agreement

On August 28, 2007, we executed a new credit agreement (the “Domestic Credit Agreement”) which provided for a five-year, $600 million revolving credit facility. The borrowings from this facility are available for general corporate purposes, including issuing letters of credit up to a $300 million sub-limit. The Domestic Credit Agreement also contains an option under which, subject to certain conditions, we may request an increase in the facility to $1 billion.

Loans under the facility bear interest at a floating rate, either a base rate as defined or the applicable euro currency rate for the relevant term plus an applicable margin. At March 31, 2011, the applicable euro currency margin was 0.5 percent, subject to adjustment based on the credit rating assigned to our senior unsecured debt. At March 31, 2011, the borrowing rate under our Domestic Credit Agreement was 0.5 percent per annum.

We had $40.0 million of borrowings under our Domestic Credit Agreement at March 31, 2011 compared to no borrowings at December 31, 2010. Letters of credit outstanding under the Domestic Credit Agreement totaled $129.0 million and $130.4 million at March 31, 2011 and December 31, 2010, respectively. As such, available funds under the Domestic Credit Agreement were $431.0 million and $469.6 million at March 31, 2011 and December 31, 2010, respectively.

#### European Credit Agreement

On December 16, 2005, our Dutch finance subsidiary executed a credit agreement (the “European Credit Agreement”) which provides for an unsecured revolving credit facility in the amount of €220 million. Borrowings may be denominated in euros or U.S. dollars. FMC and our Dutch finance subsidiary’s direct parent provide guarantees of amounts due under the European Credit Agreement. On August 13, 2010, we amended this agreement to extend its maturity to August 2012.

Loans under the European Credit Agreement bear interest at a euro currency base rate, which for loans denominated in euros is the Euro InterBank Offered Rate, and for loans denominated in dollars is London Interbank Offered Rate (“LIBOR”) in each case plus a margin. The applicable margin under our European Credit Agreement is subject to adjustment based on the credit rating assigned to our senior unsecured debt. At March 31, 2011, the applicable margin was 1.8 percent and the applicable borrowing rate under the European Credit Agreement was 2.0 percent per annum.

At March 31, 2011 and December 31, 2010, respectively, we had no revolving credit facility borrowings under the European Credit Agreement. Available funds under this facility were $309.9 million and $289.1 million at March 31, 2011 and December 31, 2010, respectively.

Among other restrictions, the Domestic Credit Agreement and the European Credit Agreement contain financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended March 31, 2011, was 1.2 which is below the maximum leverage of 3.5. Our actual interest coverage for the four consecutive quarters ended March 31, 2011, was 14.9 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at March 31, 2011.

#### Statement of Cash Flows

*Cash required by operating activities was $50.7 million for the first three months of 2011.*

Income from continuing operations of $105.4 million included net charges of $2.8 million, of which $1.6 million was for non-cash asset write-downs related to the exit of various facilities and $1.2 million of other facilities exit costs to be settled in cash, mainly for severance costs and lease obligations. Cash spending on restructuring and other charges in the first three months of

2011 was $25.4 million primarily related to the Huelva facility shutdown. Also included in income from continuing operations was $1.1 million for environmental and remediation at our operating sites, which will be spent in years beyond 2011. Net cash spending on environmental remediation at our operating sites in the first three months of 2011 was $2.1 million which was recorded against pre-existing reserves. Income from continuing operations is also adjusted for other non-cash items which include stock-based compensation expense and excess tax benefits from share-based compensation. The increase in excess tax benefits from share-based compensation was due to our ability to utilize our U.S. net operating losses which began in the second quarter of 2010. See Note 14 to our 2010 consolidated financial statements on our 2010 10-K for further discussion on these excess tax benefits.

Receivables were a use of cash of $113.9 million due to revenue increases in our businesses, particularly for Agricultural Products sales in Brazil where terms are significantly longer than in the rest of our businesses. Partially offsetting the higher receivables were accrued customer rebates which increased by $45.8 million due to sales in our Agricultural Products segment. These rebates are primarily in North America and Brazil and generally settle in the fourth quarter of each year. Accounts payable was a use of cash of $44.4 million due primarily to liquidation of vendor payables associated with our exited phosphate business in the first quarter of 2011.

Accrued pension and other postretirement benefits were a use of cash of $20.5 million which included a voluntary contribution to our U.S. defined benefit plan of $18.0 million.

*Cash required by operating activities was $1.4 million for the first three months of 2010.*

Income from continuing operations of $86.1 million included net charges of $13.4 million, of which $8.5million was for non-cash asset write-downs related to the exit of various facilities announced in 2009 and $4.9 million of other facilities exit costs to be settled in cash, mainly for severance costs and lease obligations. Cash spending on restructuring and other charges in the first quarter of 2010 was $19.6 million. Also included in restructuring and other income and charges was $2.4 million for environmental and remediation at our operating sites, which will be spent in years beyond 2010. Cash spending on environmental remediation at our operating sites in the first quarter of 2010 was $1.9 million which was recorded against pre-existing reserves.

Receivables drove the majority of our significant increase in working capital in the first three months of 2010. Receivables were a use of cash of $148.3 million due to revenue increases in our businesses, particularly for Agricultural Products sales in Brazil where terms are significantly longer than in the rest of our businesses.

Accrued pension and other post retirement benefits were a use of cash of $14.1 million which included a voluntary contribution to our U.S. defined benefit plan of $12 million.

*Cash required by operating activities of discontinued operations was $8.9 million and $6.3 million for the first three months of 2011 and 2010, respectively.*

This change was primarily due to increased net environmental spending in the three months ended March 31, 2011, compared to the prior year period.

*Cash required by investing activities was $32.5 million and $30.5 million for the first three months of 2011 and 2010, respectively.*

The slight increase in spending during the three months ended March 31, 2011, as compared to the same period in 2010 was primarily due to increased other investing spending for long-term deferred costs. These long-term deferred costs primarily represent advances to contract manufacturers.

*Cash provided by financing activities was $16.0 million and $48.7 million for the first three months of 2011 and 2010.*

This reduction is primarily due to lower borrowings under our committed credit facilities and increased short-term debt and long-term debt repayments, partially offset by the inclusion of excess tax benefits from share-based compensation during the three months ended March 31, 2011.

### Other potential liquidity needs

Our cash needs for 2011 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, contributions to our pension plans, environmental spending and restructuring. We plan to meet our liquidity needs through available cash; cash generated from operations and borrowings under our committed revolving credit facilities. We continually evaluate our options for divesting real estate holdings and property, plant and equipment that are no longer integral to any of our core operating businesses.

Projected 2011 capital expenditures are expected to be approximately 15 percent higher than 2010 levels, primarily to increase capacity in BioPolymer, lithium and soda ash.

Projected 2011 spending includes approximately $35.0 million of net environmental remediation spending. This spending does not include expected spending of approximately $6.6 million in 2011 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $23.9 million in 2011 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls above the foregoing projections.

In regard to our U.S. qualified defined benefit pension plan (“U.S. Plan”), the markets rebounded significantly in 2009 and 2010, exemplified by the S&P 500 index in the U.S. increasing 26 percent in 2009 and 15 percent in 2010. As a result of higher returns and contributions, our U.S. Plan assets increased from $708.4 million at December 31, 2009 to $842.4 million at December 31, 2010. Our U.S. Plan assets comprise approximately 93 percent of our total plan assets with the difference representing plan assets related to foreign pension plans. We are maintaining the 8.5 percent assumption for the long-term rate of return on plan assets used in 2010 for 2011. In developing the assumption for the long-term rate of return on plan assets for our U.S. Plan, we take into consideration the technical analysis performed by our outside actuaries, including historical market returns, information on the assumption for long-term real returns by asset class, inflation assumptions, and expectations for standard deviation related to these best estimates. We also consider the historical performance of our own plan's trust, which earned 15 percent in 2010 and has earned a compound annual rate of return of approximately 11 percent over the last 20 years (which is in excess of comparable market indices for the same period) as well as other factors. Given an actively managed investment portfolio, the expected annual rate of return by asset class for our portfolio, using geometric averaging, and after being adjusted for an estimated inflation rate of approximately 2.5 percent, is between 8.6 percent and 10.3 percent for equities, and between 4.2 percent and 6.3 percent for fixed-income investments, which generates a total expected portfolio return that is in line with our assumptions for the rate of return on assets. In order to reduce future funding volatility, we intend to contribute $55.0 million in 2011, which is in excess of the minimum requirements versus contributions of $80.0 million in 2010 and $75.0 million in 2009. We do not believe that the additional contribution will have a significant negative impact on our current and future liquidity needs. However, a continuation of the volatility of interest rates and negative equity returns under current market conditions may require greater contributions to the Plan in the future.

On April 21, 2011, we paid dividends totaling $10.8 million to our shareholders of record as of March 31, 2011. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of March 31, 2011.

On October 24, 2008, the Board of Directors authorized the repurchase of up to $250 million of our common stock. At December 31, 2010, $54.8 million remained unused of the 2008 authorization. On February 18, 2011, the Board authorized the repurchase of up to an additional $250 million of our common stock for a total of $304.8 million. The repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. During the three months ended March 31, 2011, no shares were repurchased under the publicly announced repurchase program. From time to time we acquire shares from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

On July 21, 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act was signed into law. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing, largely within 360 days of passage, the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe the liquidity requirements will be adequately met by the sources available to us.

### Commitments

We provide guarantees to financial institutions on behalf of certain Agricultural Products customers, principally in Brazil, for their seasonal borrowing. The total of these guarantees was $20.8 million and $24.1 million at March 31, 2011 and December 31, 2010, respectively, and are recorded on the condensed consolidated balance sheets for each date as “Guarantees of vendor financing”.

We guarantee repayment of some of the borrowings of certain foreign affiliates accounted for using the equity method for investments. As of March 31, 2011, these guarantees had maximum potential payments of $7.2 million as compared to $6.2 million as of December 31, 2010.

Short-term debt consisted of foreign credit lines at March 31, 2011 and December 31, 2010. We provide parent-company guarantees to lending institutions providing credit to our foreign subsidiaries.

In connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale. Our indemnification obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover certain of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.

### Contingencies

On January 28, 2005, we and our wholly owned subsidiary Foret received a Statement of Objections from the European Commission concerning alleged violations of competition law in the hydrogen peroxide business in Europe during the period 1994 to 2001. All of the significant European hydrogen peroxide producers also received the Statement of Objections. We and Foret responded to the Statement of Objections in April 2005 and a hearing on the matter was held at the end of June 2005. On May 3, 2006, we received a notice from the European Commission indicating that the European Commission had imposed a fine on us and Foret in the aggregate amount of €25.0 million as a result of alleged violations during the period 1997-1999. In connection with this fine, we recorded an expense of $30.0 million (reflecting then-prevailing exchange rates) in our consolidated statements of income for the year ended December 31, 2006. This expense was included as a component of “Restructuring and other charges (income)”. Both we and Foret have appealed the decision of the European Commission. The Foret appeal was argued before the Court of First Instance on March 4, 2010 and the FMC appeal was argued in May of 2010, but no decision has been rendered on either appeal. During the appeal process, interest accrues on the fine, which as of March 31, 2011, was at a rate of 4.0 percent per annum. We have provided a bank letter of credit in favor of the European Commission to guarantee our payment of the fine and accrued interest. At March 31, 2011, the amount of the letter of credit was €30.5 million (U.S. $43.0 million).

In February 2005, putative direct and indirect purchaser class action complaints were filed against six U.S. hydrogen peroxide producers (and certain of their foreign affiliates) in various federal courts alleging violations of antitrust laws. Related cases were also filed in various state courts. In January 2009, FMC reached an agreement to settle with the direct purchaser class for $10 million, with a pro rata credit for opt outs. The $10 million figure was included as a component of “Restructuring and other charges (income)” in our consolidated statements of income for the year ended December 31, 2008. Ten companies (predominantly paper producers) opted out of this class settlement. FMC settled with two of the ten companies for an amount within the opt out credit described above. The remaining eight opt outs filed suit against FMC and, in some cases, Foret. These cases were assigned to the same judge as the class action. FMC's motion to dismiss the opt out claims to the extent they were based on foreign purchases was granted on April 1, 2010. FMC has settled the remaining claims of these eight opt outs for an aggregate of $1.7 million which is net of a $0.3 million opt out credit. Another individual opt out case was dismissed following the bankrupt opt out's decision to participate in the class settlement. FMC settled the indirect purchaser class claims for $0.25 million. The settlement has been finally approved by the Court, and all remaining state court cases have been dismissed with prejudice. We recorded the $2.0 million as a component of “Restructuring and other charges (income)” in our consolidated statements of income for the year ended December 31, 2010. As a result, all U.S. litigation against FMC regarding alleged price fixing in the hydrogen peroxide industry is now concluded. We still face putative class actions against FMC and five other major hydrogen peroxide producers in provincial courts in Ontario, Quebec and British Columbia under the laws of Canada. Four of the defendants have settled these claims for a total of approximately $20.5 million. On September 28, 2009, the Ontario Superior Court of Justice certified a class of direct and indirect purchasers of hydrogen peroxide. FMC moved for leave to appeal the class certification decision, which was denied in June 2010. The Company intends to defend these cases. Since the proceedings are in the preliminary stages with respect to the merits, we believe an exposure of loss cannot be reasonably estimated.

Like hundreds of other industrial companies, we have been named as one of many defendants in asbestos-related personal injury litigation. Most of these cases allege personal injury or death resulting from exposure to asbestos in premises of FMC or to asbestos-containing components installed in machinery or equipment manufactured or sold by discontinued operations. We intend to continue managing these cases in accordance with our historical experience. We have established a reserve for this litigation within our discontinued operations and believe that any exposure of a loss in excess of the established reserve cannot be reasonably estimated.

In late June 2004, we were served in a lawsuit captioned “Lewis et al v. FMC Corporation”, which was filed in United States District Court for the Western District of New York. The suit was brought by thirteen residents of Middleport, New York who alleged that we violated certain state and federal environmental laws and sought injunctive relief and monetary damages for personal injuries and property damage in connection with such alleged violations. A motion for summary judgment was decided in favor of the Company on March 29, 2011. On April 28, 2011, the plaintiffs filed an appeal of that decision to the U.S. Court of Appeals for the Second Circuit.

We have certain other contingent liabilities arising from litigation, claims, performance guarantees and other commitments incident to the ordinary course of business. Based on information currently available and established reserves, the ultimate resolution of our known contingencies, including the matters described in Note 17 to our condensed consolidated financial statements in this Form 10-Q, is not expected to have a material adverse effect on our consolidated financial position or liquidity. However, there can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on our consolidated financial position, results of operations or liquidity.

### Climate Change

A detailed discussion on climate change can be found in Part II, Item 7 of our 2010 consolidated financial statements on our 2010 10-K. There have been no material changes to climate change from the information reported therein.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair Value Measurements

See Note 16 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At March 31, 2011, our net financial instrument position was a net liability of $3.9 million compared to a net liability of $6.8 million at December 31, 2010. The change in the net financial instrument position was primarily due to lower unrealized losses in our commodity and foreign exchange portfolios.

### Commodity Price Risk

Energy costs are approximately nine percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at March 31, 2011 and December 31, 2010, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in a decrease in the net liability position of $3.0 million at March 31, 2011, compared to a $3.4 million decrease of the net liability position at December 31, 2010. A 10 percent decrease in energy market prices would result in an increase of $3.3 million in the net liability position at March 31, 2011, compared to an increase of $3.4 million of the net liability position at December 31, 2010.

In the second quarter of 2010, our Agricultural Products segment began entering into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of March 31, 2011 our net financial instrument position was immaterial. As of December 31, 2010, we had no such contracts in place.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at March 31, 2011 and December 31,

2010, with all other variables (including interest rates) held constant. A 10 percent strengthening of hedged currencies versus our functional currencies would have resulted in an decrease of $48.9 million in the net asset position at March 31, 2011, compared to an increase of $33.3 million in the net liability position at December 31, 2010. As a result, at March 31, 2011, the net asset position would have become a net liability position. A 10 percent weakening of hedged currencies versus our functional currencies would have resulted in an increase of $49.7 million in the net asset position at March 31, 2011, compared to a decrease of $31.1 million in the net liability position at December 31, 2010. As a result, at December 31, 2010, the net liability position would have become a net asset position.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of March 31, 2011 and December 31, 2010, we had no interest rate swap agreements.

Our debt portfolio, at March 31, 2011, is composed of 89 percent fixed-rate debt and 11 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Domestic and European Credit Agreements, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at March 31, 2011, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $0.2 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $0.1 million for the first three months of 2011.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,493 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended March 31, 2011, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

#### Report of Independent Registered Public Accounting Firm

The Board of Directors

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of March 31, 2011, the related condensed consolidated statements of income for the three months ended March 31, 2011 and 2010 and the condensed consolidated statements of cash flows for the three months ended March 31, 2011 and 2010. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2010, and the related consolidated statements of income, changes in equity, cash flows and comprehensive income for the year then ended (not presented herein) and in our report dated February 22, 2011, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2010, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

### /s/ KPMG LLP

Philadelphia, Pennsylvania

May 5, 2011

Filed May 5, 2011.
Source: SEC EDGAR, the filing index for accession 0000037785-11-000006. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
